Align Technology Trims Holdings for Factory Mutual Insurance

Institutional investor reduces stake in medical equipment provider by 39% in Q4

Apr. 11, 2026 at 8:38am

Got story updates? Submit your updates here. ›

A high-contrast, close-up image of the intricate mechanical components that power Align Technology's Invisalign system, conveying the advanced engineering and technology behind the company's innovative dental products.The complex inner workings of Align Technology's Invisalign system reflect the company's commitment to cutting-edge digital orthodontic solutions.Tempe Today

Factory Mutual Insurance Co. has trimmed its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 39% in the fourth quarter, according to a recent SEC filing. The institutional investor now owns 146,643 shares of the medical equipment provider's stock, down from 240,293 shares previously.

Why it matters

Align Technology is a leading provider of digital orthodontic solutions, including the popular Invisalign clear aligner system. Changes in institutional ownership can signal shifts in investor sentiment and market expectations for the company.

The details

According to the 13F filing, Factory Mutual Insurance sold 93,650 shares of Align Technology stock during the fourth quarter. The institutional investor now owns about 0.20% of the company's outstanding shares, down from 0.33% previously. Align Technology's stock price has fluctuated in recent months amid broader market volatility, closing at $173.14 on Friday.

  • Factory Mutual Insurance filed its Q4 2025 13F report on April 11, 2026.

The players

Align Technology, Inc.

A medical equipment provider that pioneered the use of digital technology in orthodontics through the development of the Invisalign system.

Factory Mutual Insurance Co.

An institutional investor that has reduced its stake in Align Technology by 39% in the fourth quarter.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the shifting landscape of institutional ownership in Align Technology, as one major investor has pared back its position. While the reasons behind Factory Mutual's decision are not explicitly stated, it reflects the broader volatility and uncertainty facing the medical technology sector.